Age: 26.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Rash, SARS-CoV-2 test
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (tested positive for COVID/ tested positive for COVID. He further stated after COVID symptoms started going away) and RASH (he developed skin rashes on his body, crotch and inner part of his thigh, under part of his arms where veins are, hands, feet and knuckles on his feet/ like he athlete's foot) in a 26-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 045J21A) for COVID-19 vaccination. Concurrent medical conditions included HIV disease. On 01-Dec-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In January 2022, the patient experienced COVID-19 (tested positive for COVID/ tested positive for COVID/ He further stated after COVID symptoms started going away) and RASH (he developed skin rashes on his body, crotch and inner part of his thigh, under part of his arms where veins are, hands, feet and knuckles on his feet/ like he athlete's foot). In January 2022, RASH (he developed skin rashes on his body, crotch and inner part of his thigh, under part of his arms where veins are, hands, feet and knuckles on his feet/ like he athlete's foot) had resolved. At the time of the report, COVID-19 (tested positive for COVID/ tested positive for COVID/ He further stated after COVID symptoms started going away) was resolving. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In January 2022, SARS-CoV-2 test: positive (Positive) He tested positive for COVID. Concomitant medications included vitamins and HIV medicine. In early JAN 2022, the patient started feeling sick and tested positive for COVID and about 24 hours later he developed skin rashes on his body. Patient stated that after COVID symptoms started going away, the rash started going away as well. No treatment details were provided. Company comment: This spontaneous case concerns a 26-year-old male patient with a relevant medical history of HIV infection, who experienced the unexpected non serious event of COVID-19 (AESI) after mRNA- 1273 vaccine. The onset of the event occurred approximately 1 month after the third dose of mRNA- 1273 vaccine (unknown dosage). Information regarding the initial schedule of vaccination was not disclosed. Based on the information available, the disease was mild. Additionally, rash was experienced, and could also be in connection with COVID-19. At the time of the report, COVID-19 symptoms were resolving. Very limited information was provided regarding HIV infection and baseline CD4 count, which could be a confounder. The benefit-risk relationship of mRNA- 1273 vaccine is not affected by this report. Sender's Comments: This spontaneous case concerns a 26-year-old male patient with a relevant medical history of HIV infection, who experienced the unexpected non serious event of COVID-19 (AESI) after mRNA- 1273 vaccine. The onset of the event occurred approximately 1 month after the third dose of mRNA- 1273 vaccine (unknown dosage). Information regarding the initial schedule of vaccination was not disclosed. Based on the information available, the disease was mild. Additionally, rash was experienced, and could also be in connection with COVID-19. At the time of the report, COVID-19 symptoms were resolving. Very limited information was provided regarding HIV infection and baseline CD4 count, which could be a confounder. The benefit-risk relationship of mRNA- 1273 vaccine is not affected by this report.